Patient21 Pitch Deck: All 8 Slides + Teardown

Patient21’s Series C deck is a masterclass in brevity for a complex business model. By positioning themselves as a 'digi-physical' ecosystem rather than just a software provider or a clinic chain, they address the scalability concerns of traditional healthcare. The deck highlights their ownership of 50+ clinics and a proprietary software stack that manages the entire patient journey—from SEO-driven acquisition to AI-supported diagnosis. With 25,000 monthly patient visits and a 4.9/5.0 satisfaction rating, the narrative focuses on proven operational excellence and a massive €363bn European mar…

Key takeaways

• The company defines itself as a 'digi-physical outpatient network' to bridge the gap between pure tech and traditional brick-and-mortar (Slide 2).
• The business model relies on three pillars: owned clinics (hardware), proprietary software (operating system), and a patient-facing health assistant (data) (Slide 3).
• Traction is demonstrated by 50+ clinics in Germany and 25,000 monthly patient visits (Slide 4).
• The market size for outpatient services in the EU is valued at €363bn, with dental services representing a €93bn subset (Slide 5).
• The proprietary software suite includes specific modules like 'Availy' for booking, 'Ana' for check-in, 'Claire' for treatment plans, and 'Passenger' for patient communication (Slide 6).
• Competitive differentiation is framed against a 'Typical dental practice,' highlighting 'No waiting times' and 'AI-supported decision making' (Slide 7).
• Patient satisfaction is exceptionally high, with a 4.9 out of 5.0 average NPS across all doctors (Slide 8).
• Referral-based growth is significant, with 25% of visits originating from patient referrals (Slide 8).

Frequently asked questions

Why is the Patient21 deck so short for a Series C round?

At the Series C stage, investors are often already familiar with the company's core metrics through data rooms. This 8-slide deck likely served as a high-level executive summary to frame the narrative of 'digi-physical' dominance before diving into deeper due diligence. It focuses on the 'why' and 'how' rather than exhaustive data.

What does 'digi-physical' actually mean in this context?

It refers to Patient21's strategy of vertically integrating the healthcare experience. Unlike Zocdoc (which is just a marketplace) or a traditional dentist (which is just a clinic), Patient21 owns the physical clinics and the software that runs them. This allows them to control the data and the patient experience from end to end.

How does Patient21 justify its valuation in a low-margin clinic business?

By emphasizing their proprietary 'Operating System' (Slide 3) and 'AI-supported decision making' (Slide 7). They are positioning the clinics as the 'hardware' that runs their high-margin software, suggesting that their tech stack makes these clinics significantly more efficient and profitable than traditional practices.

What is the significance of the 25% referral rate?

In healthcare, customer acquisition costs (CAC) can be high. A 25% referral rate (Slide 8) indicates strong organic growth and high brand trust. For investors, this suggests that the business can scale more efficiently than competitors who rely solely on paid marketing.

Is the lack of a team slide a red flag?

In a Series C deck, the 'team' is often proven by the results (50+ clinics, 25k visits). While unusual for an early-stage deck, at this level, the founders' reputations and the company's scale often speak for themselves, though a team slide is still recommended for most decks.

Patient21 pitch deck: the facts

Company

Patient21

Year

2024

Stage

Series C

Slides

8

Sector

Healthcare

Deck type

Overview / Pitch Deck

Outcome

$108M Raised

Headquarters

Germany

Patient21 pitch deck PDF

The full Patient21 deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Patient21 pitch deck was used for

This deck is Patient21’s Series C fundraising presentation used for its approximately €100m ($108m) round announced in May 2023, a later‑stage VC round for its hybrid digital‑physical outpatient network.[1][2][4][9][11][14] The company, headquartered in Berlin and founded in 2019, runs a network of technology‑enabled clinics—primarily dental—powered by its own software platform.[1][4][11][14][15] The capital was raised to further develop Patient21’s software platform, build AI‑driven diagnostic tools from X‑rays, and expand its clinic network beyond Germany into other European markets.[4][6][8][9] Although the library labels the deck as 2024 Series C, the externally verifiable fundraise tied to this deck is the May 2023 Series C round; any later deck reuse would be a continuation of this same round.[1][4][9][11][14]

Business model: Patient21 operates a hybrid "digi‑physical" outpatient care network that combines a digital healthcare platform with brick‑and‑mortar clinics, with a core focus on acquiring and outfitting dental clinics using proprietary management software for appointments, patient data and electronic health records.[1][4][9][14]

Lead investor

Pitango[2][3][4][6][7][8][9]

Investors

Pitango, Target Global, Piton Capital, PICO Venture Partners, Bertelsmann Investments, Artian Investments Limited, IPF Partners (debt financing provider), Angel investors including Mario Kohle and Maria Raga

Founded

2019[11][14][15]

Founders

Christopher Muhr, Nicolas Hantzsch, Sebastian Duong[11][15]

Headquarters

Berlin, Germany[1][4][11][14][15]

Industry

Healthtech / Digital healthcare platform with brick‑and‑mortar clinics[1][4][9][14][15]

Round: Series C (later‑stage VC, mix of equity and debt). [2][4][8][9][11][12][14]

Year: 2023[1][2][4][6][8][9][11][12][14]

Raised: Approximately €100m (~$108m), mostly equity with about 30% structured as debt, in a Series C round announced in May 2023.[2][4][6][8][9][11][12][14]

Total funding: Approximately $250M across multiple funding rounds as of 2026, including a $108M Series C in 2023.[11][13]

Use of funds as presented: Develop and scale Patient21’s proprietary healthcare software platform; build a generative AI tool to help diagnose from X‑rays; expand its clinic network and operations beyond Germany into two additional European countries; and prepare to sell its software as a white‑label solution starting in 2024.[4][6][8]

What happened after the Patient21 deck

The deck supported Patient21’s May 2023 Series C round, through which it secured approximately €100m (~$108m) in mixed equity‑and‑debt financing to scale its digi‑physical clinic network, further develop its proprietary software platform, and pursue AI diagnostics and international expansion.[2][4][6][8][9][11][12]

• By the time of the Series C, Patient21 had grown to 53 outpatient clinics across Germany, including 43 dental clinics.[1
• The company closed a approximately €100m ($108m) Series C round in May 2023, largely equity, led by Pitango with multipl
• Following the raise, Patient21 announced plans to expand beyond Germany into two additional European markets and to deve

What the Patient21 deck got right

• Compelling hybrid digi‑physical model. Patient21 articulates a differentiated **digi‑physical outpatient model** that integrates a digital platform with owned or acquired brick‑and‑mortar clinics, offering both operational control and software‑driven scalability in a sector where many players are either purely digital or purely physical.[1][4][9][14]
• Demonstrated clinic scale and traction. At the time of the Series C deck, Patient21 had already scaled to **53 outpatient clinics in Germany, including 43 dental clinics**, demonstrating significant operational traction and a strong base for further geographic expansion.[1]
• Large, well‑validated Series C financing. The company secured a **€100m (~$108m) Series C round led by Pitango**, with participation from multiple reputable investors and a majority equity component, signaling strong market validation and providing substantial growth capital.[2][4][6][8][9][11][12][14]
• Forward‑looking software and AI strategy. Patient21’s strategy includes **developing proprietary software and generative AI tools for X‑ray‑based diagnostics**, plus a plan to sell its software platform as a white‑label solution, creating potential for higher‑margin, scalable software revenues on top of clinic operations.[4][6][8]
• Experienced founding team. The founding team includes **Christopher Muhr, former COO of AUTO1**, alongside co‑founders Nicolas Hantzsch and Sebastian Duong, bringing experience in scaling complex, multi‑location operations and technology‑enabled services businesses.[11][13][15]
• Focused vertical beachhead in dental care. By focusing first on **dental clinics** and standardizing them with its proprietary systems, Patient21 can show a clear vertical beachhead, with opportunities to expand into other outpatient specialties once the model is proven.[1][4][14]

What could have been stronger

• Limited clarity on equity vs. debt composition of the Series C. External reporting indicates that roughly 30% of the €100m Series C was structured as debt from IPF Partners, but the deck summary in the library does not clarify whether or how the mix of equity versus debt was presented, which affects investors’ view of risk and dilution.[2][4][8][9]
• Sparse visibility into clinic‑level economics and profitability. The externally reported clinic count (53 outpatient clinics, 43 dental) is material traction, but the OCR for the deck contains no readable traction slide, suggesting that if they used only 8 slides, investors may have limited visibility into unit economics, clinic‑level profitability and payback period.[1]
• Unclear revenue mix between physical clinics and software/AI offerings. While public sources highlight plans for AI‑based diagnostic tools and white‑label software sales starting in 2024, it is unclear from the deck summary how concretely these future software and AI revenues were modeled versus the core clinic network, leaving potential ambiguity in the balance between services and SaaS.[4]

How an investor would read this deck

What draws attention

• Clear articulation of a **digi‑physical** model that marries software with owned or acquired clinics, offering operational leverage through standardized processes and EHR‑driven workflows.[1][4][9][14]
• Evidence of **scale in Germany**, with 53 outpatient clinics (including 43 dental) already operating, indicating execution capability and a platform for cross‑selling diagnostics and software.[1]
• Series C round size of **€100m (~$108m)**, mostly equity, led by a prominent healthcare‑focused VC (Pitango), with participation from multiple brand‑name investors, signaling strong validation.[2][4][6][8][9]
• Stated plans to use funds to **develop proprietary software, build generative AI tools for X‑ray‑based diagnostics, and expand to additional European markets**, which can support both margin expansion and geographical growth.[4][6][8]
• Founding team experience, particularly co‑founder Christopher Muhr’s background as former COO of AUTO1, suggesting familiarity with scaling operations and multi‑site businesses.[4][13]

Risks that stand out

• The model relies heavily on acquiring and integrating clinics, which can introduce operational complexity and variation in quality; scaling beyond Germany into new European markets may strain management and systems.[1][4]
• The announced generative AI diagnostic tools and white‑label software strategy add technical, regulatory and execution risk, especially if significant future growth is predicated on yet‑to‑be‑proven AI products.[4]
• A meaningful portion of the Series C round (about 30%) is structured as debt financing, which can increase financial leverage and reduce flexibility in downturns.[2][4][8][9]
• Competitive pressure from both traditional clinic chains and other digital health platforms could compress margins, particularly if the software platform does not become a widely adopted product beyond Patient21’s own network.[4][14]

Questions this deck invites

• How do clinic‑level economics (patient volume, revenue per visit, clinician productivity, fixed costs) look across the existing network, and what is the typical payback period for a newly acquired or refurbished clinic?[1][4]
• What proportion of Patient21’s current and projected revenue comes from in‑clinic services versus SaaS or AI‑driven software products, and how defensible are margins in each segment given reimbursement and competition?[4][14]
• How is the debt portion of the €100m Series C structured (tenor, covenants, security), and what constraints does it impose on future fundraising or cash flow management?[2][8][9]
• What is the regulatory and data‑protection posture for Patient21’s proprietary platform and planned AI diagnostics, particularly with respect to medical device approvals and GDPR compliance in existing and target markets?[4]
• What are the key risks and timelines around expanding beyond Germany into two additional European countries, including clinic acquisition pipeline, regulatory licensing, and localization of the software platform?[4]

What founders can take from the Patient21 deck

• Building a **digi‑physical narrative**—clearly explaining how software and physical assets combine into a single patient journey—can attract later‑stage capital even in complex, operationally heavy models.[1][4][9][14]
• Demonstrating **meaningful scale in a core market** (over 50 clinics in Germany) before raising a large Series C helps investors see proof of execution and a platform for regional expansion.[1][4]
• Using a mix of **equity and debt** in a growth round allows companies to access larger capital pools, but it requires transparent communication of structure and implications to equity investors.[2][4][8][9]
• Articulating specific **use of funds**—such as software development, AI diagnostics from X‑rays, and expansion into named new markets—gives investors a concrete view of how capital turns into growth initiatives.[4][6][8]
• Highlighting a founding team with **prior scale‑up experience** (e.g., a former COO of a unicorn marketplace) can strengthen investor confidence in the ability to manage a multi‑site, operations‑heavy healthtech business.[4][13]
• Positioning the platform to later support **white‑label software sales** to external clinics shows how an initially asset‑heavy model can evolve into a more scalable software‑enabled network.[4]

Patient21 pitch deck: common questions

What does Patient21 do?

Patient21 is a Berlin‑based healthtech company that runs a hybrid "digi‑physical" outpatient network, combining a digital healthcare platform with brick‑and‑mortar clinics—primarily dental—supported by proprietary software for bookings, patient data and electronic health records.[1][4][9][14][15]

When did Patient21 raise its Series C round and how much did it raise?

The Series C round tied to this deck was announced in May 2023, when Patient21 raised about €100m ($108m) in later‑stage VC funding led by Pitango, with a mix of roughly 70% equity and 30% debt.[2][4][6][8][9][11][12][14]

Who invested in Patient21’s Series C round?

The Series C equity was led by Israeli VC Pitango, with participation from Bertelsmann Investments, Artian Investments, Target Global, Piton Capital, PICO Venture Partners and several angels, while the debt component was provided by IPF Partners.[2][4][7][8][9]

How large is Patient21’s clinic network and what were its plans for the Series C funds?

At the time of the Series C, Patient21 operated more than 50 outpatient clinics across Germany, including over 40 dental clinics; the company planned to use the funding to develop its software platform, build generative AI diagnostics from X‑rays, and expand into two additional European countries.[1][4]

Who founded Patient21 and where is it based?

Patient21’s founders include Christopher Muhr (former COO of AUTO1 Group) along with co‑founders Nicolas Hantzsch and Sebastian Duong, and the company was founded in 2019 and is headquartered in Berlin, Germany.[11][13][15]

Sources

Funding and outcome facts on this page were researched on 2026-08-30 from the pages below.

• Patient21: Hybrid Healthtech Raises $108 Million Series C
• IPF Partners Closes a Debt Financing with Patient21, as ...
• Pitango leads €100m Patient21 series C round - Private Equity Wire
• Digi-physical health platform Patient21 raises sector's ...
• Patient 21: Funding, Team & Investors
• German Digital Health Startup Patient21 Secures $108M
• Digital healthcare company Patient21 Secures €100 million in ...
• Patient21 Nabs $108M To Expand In-Person Health Care ...

Related fundraising guides (24)

• Eliyan Pitch Deck Teardown: Solving the Chiplet Interconnect Bottleneck for AI
• Chptr Pitch Deck Teardown: Modernizing the $120B Death Industry for Digital Natives
• Altana Pitch Deck Teardown: Mapping the Global Supply Chain with Federated Learning
• Yalo Pitch Deck Teardown: Dominating Enterprise Conversational AI via WhatsApp
• Hone Pitch Deck Teardown: Defining the 'Missing Middle' of Corporate Learning
• EVERY Pitch Deck Teardown: A $175M Masterclass in Precision Fermentation Storytelling
• Circles Pitch Deck Teardown: A $16.5M Series A Bet on Scalable Peer Support
• Arize AI Pitch Deck Teardown: A Masterclass in Category Creation and Market Timing
• Limetree Pitch Deck Teardown: A Case Study in Early-Stage Family Media Preservation
• Ideon Technologies Pitch Deck Teardown: Using Muon Tomography to De-Risk Mining Exploration
• Fintor Pitch Deck Teardown: A $6.2M Seed Round Built on Fractional Real Estate Liquidity
• Code First Girls Pitch Deck Teardown: A Masterclass in B2B Social Impact Scaling
• Avo Pitch Deck Teardown: A B2B2C Strategy for Last-Mile Logistics Dominance
• Kinnu Pitch Deck Teardown: A Masterclass in Social Proof and Product-Led Growth
• Martian Pitch Deck Teardown: A $9M Seed Masterclass in LLM Orchestration and Interpretability
• Green Li-ion Pitch Deck Teardown: A Masterclass in Supply Chain Disruption for Battery Recycling
• Dalan Animal Health Pitch Deck Teardown: A $3.5M Seed for the First Honeybee Vaccine
• Brag House Pitch Deck Teardown: Targeting the Casual Collegiate Esports Market
• Affini-T Therapeutics Pitch Deck Teardown: A $175M Masterclass in Biotech Platform Credibility
• Heali Pitch Deck Teardown: Leveraging Clinical Validation to Secure a $3M Seed Round
• Haystack Oncology Pitch Deck Teardown: A Masterclass in Pedigree-Driven Biotech Fundraising
• EcoLocked Pitch Deck Teardown: Decarbonizing Construction via Biochar Admixes
• Buynomics Pitch Deck Teardown: A Data-Driven Case for Behavioral Pricing Intelligence
• airSlate Pitch Deck Teardown: A $51.5M Series C Masterclass in Growth and Product Consolidation

Decks from the same year (1)

• 2024 pitch deck examples

Decks from the same region (1)

• European pitch deck examples

Decks with a similar raise (1)

• Pitch decks that raised $50M to $250M

Browse companies alphabetically (1)

• Pitch decks from companies starting with P

More pitch deck teardowns (16)

• Particle Pitch Deck Breakdown: A Masterclass in Enterprise IoT Case Studies
• Party Round Pitch Deck Breakdown: A Masterclass in Minimalist, Brand-First Seed Fundraising
• PartyRound Pitch Deck Teardown: A 7-Slide Masterclass in Minimalist Product Storytelling
• Pasqal Pitch Deck Breakdown: Selling the Scalability of Neutral Atom Quantum Computing
• Patchwork Health Pitch Deck Teardown: A Category-Creation Play for Healthcare Workforce SaaS
• Pathlight Pitch Deck Breakdown: Defining the $50B Realtime Performance Management Category
• Path Pitch Deck Breakdown: A $5.35M Seed Round Built on Employer-Facing Addiction Care
• Pathrise Pitch Deck Breakdown: A Masterclass in Income Share Agreement Traction
• PatientSchedulingApp Pitch Deck Teardown: A Hardware-Dependent NHS Efficiency Play
• Patriot Shield Pitch Deck Teardown: A High-Stakes Bet on Hemp Logistics and Public Markets
• Paubox Pitch Deck Breakdown: A 7-Slide Masterclass in Extreme Minimalism
• Pave Pitch Deck Teardown: A Masterclass in Data Flywheels and Explosive SaaS Growth
• Pawprint Pitch Deck Breakdown: A Minimalist Approach to Pet Health Records
• Pawzii Pitch Deck Teardown: Using Pet Licensing as a Wedge for Data-Driven E-Commerce
• Payhawk Pitch Deck Breakdown: A Masterclass in Cohort Retention and Enterprise Spend Control
• Paykind Pitch Deck Breakdown: Solving the 40% Leakage in African Aid and Remittance

Recently published pitch deck teardowns (12)

• Hoorah Pitch Deck Teardown: A Minimalist Approach to Employee Feedback and Soft KPIs
• HousePouch Pitch Deck Teardown: A Curated Marketplace for Home Furnishing
• MESH Pitch Deck Teardown: A Masterclass in the 'Airbnb for Startups' Narrative
• Lusabo Group Pitch Deck Teardown: A $35M Export-Focused Hydroponic Agriculture Project
• Ivyclique Pitch Deck Teardown: An API-Centric Approach to Content Automation
• Islet Sciences Pitch Deck Teardown: A Deep Dive into Porcine Islet Transplantation Tech
• Iveda Pitch Deck Teardown: Leveraging Telecom Partnerships for Cloud Video Surveillance
• Jago Studios Pitch Deck Teardown: Leveraging Nostalgia and IP for Mobile Gaming
• Iveda Pitch Deck Teardown: Navigating the Transition from Legacy Hardware to Cloud VSaaS
• Joyixir Pitch Deck Teardown: A Regional Gaming Studio Seeking Global Expansion
• 1-Page Pitch Deck Teardown: A Referral-First Approach to Enterprise Talent Sourcing
• Justbeth Table Water Pitch Deck Teardown: A Social Enterprise Model for Nigerian Clean Water

Fundraising library · Pitch deck examples · Investor directory · Founder database